000 | 01158 a2200325 4500 | ||
---|---|---|---|
005 | 20250513035352.0 | ||
264 | 0 | _c19950929 | |
008 | 199509s 0 0 eng d | ||
022 | _a1060-0280 | ||
024 | 7 |
_a10.1177/106002809502900516 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKeating, A | |
245 | 0 | 0 |
_aCarbamazepine-induced Stevens-Johnson syndrome in a child. _h[electronic resource] |
260 |
_bThe Annals of pharmacotherapy _cMay 1995 |
||
300 |
_a538-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarbamazepine _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEpilepsy, Generalized _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aStevens-Johnson Syndrome _xchemically induced |
650 | 0 | 4 |
_aSuperinfection _xdrug therapy |
650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
700 | 1 | _aBlahunka, P | |
773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 29 _gno. 5 _gp. 538-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002809502900516 _zAvailable from publisher's website |
999 |
_c7654573 _d7654573 |